Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
AFCG Quote, Financials, Valuation and Earnings
Last price:
$4.53
Seasonality move
:
-5.57%
Day range:
$4.46 - $4.60
52-week range:
$4.32 - $10.88
Dividend yield:
22.91%
P/E ratio:
4.59x
P/S ratio:
2.79x
P/B ratio:
0.51x
Volume:
85K
Avg. volume:
216.3K
1-year change:
-52.26%
Market cap:
$102.6M
Revenue:
$35.8M
EPS (TTM):
$0.99
Analysts' Opinion
-
Consensus RatingAdvanced Flower Capital has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $8.76, Advanced Flower Capital has an estimated upside of 92.95% from its current price of $4.54.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $4.54.
Fair Value
-
According to the consensus of 6 analysts, Advanced Flower Capital has 92.95% upside to fair value with a price target of $8.76 per share.
AFCG vs. S&P 500
-
Over the past 5 trading days, Advanced Flower Capital has underperformed the S&P 500 by -2.85% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Advanced Flower Capital does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Advanced Flower Capital revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Advanced Flower Capital reported revenues of $6M.
Earnings Growth
-
Advanced Flower Capital earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Advanced Flower Capital reported earnings per share of $0.18.
Enterprise value:
208.2M
EV / Invested capital:
--
Price / LTM sales:
2.79x
EV / EBIT:
7.52x
EV / Revenue:
6.01x
PEG ratio (5yr expected):
0.05x
EV / Free cash flow:
10.90x
Price / Operating cash flow:
5.06x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
5.16%
Net Income Margin (TTM):
60.3%
Return On Equity:
8.48%
Return On Invested Capital:
5.35%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $69.4M | $47.8M | $34.7M | $9M | $6M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.77 | $0.52 | $0.99 | -$0.01 | $0.18 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $128M | $94.4M | $84.5M | $92.4M | $5.1M | |
| Total Assets | $221.5M | $454.1M | $447.8M | $476.4M | $321.7M | |
| Current Liabilities | $4.5M | $18.7M | $20.2M | $76.6M | $31.1M | |
| Total Liabilities | $5.2M | $117.6M | $110M | $165.8M | $120.9M | |
| Total Equity | $216.3M | $336.5M | $337.9M | $310.6M | $200.8M | |
| Total Debt | -- | $96.7M | $87.6M | $148.2M | $111M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $31M | $23.2M | $19.1M | $6.4M | $3.9M | |
| Cash From Investing | $28.7M | -$40.4M | $30M | -$53.9M | -$19.1M | |
| Cash From Financing | -$42.7M | $18.8M | -$128M | $8.2M | -$85.1M | |
| Free Cash Flow | $31M | $23.2M | $19.1M | $6.4M | $3.9M | |
AFCG
Sector
Market Cap
$102.6M
$627.9M
Price % of 52-Week High
41.73%
89.42%
Dividend Yield
22.91%
1.97%
Shareholder Yield
--
4.06%
1-Year Price Total Return
-52.26%
7.77%
Beta (5-Year)
--
0.585
Dividend yield:
22.91%
Annualized payout:
$1.77
Payout ratio:
179.56%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.55
200-day SMA
Sell
Level
$7.49
Bollinger Bands (100)
Sell
Level
4.46 - 6.92
Chaikin Money Flow
Sell
Level
-20.1M
20-day SMA
Sell
Level
$4.61
Relative Strength Index (RSI14)
Sell
Level
43.50
ADX Line
Sell
Level
22.84
Williams %R
Neutral
Level
-70.5825
50-day SMA
Sell
Level
$4.99
MACD (12, 26)
Sell
Level
-0.14
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Sell
Level
-11.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.6213)
Buy
CA Score
(Annual)
Level (0.2412)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.0367)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team’s deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.
Stock Forecast FAQ
In the current month, AFCG has received 3 Buy ratings 3 Hold ratings, and 0 Sell ratings. The AFCG average analyst price target in the past 3 months is $8.76.
-
Where Will Advanced Flower Capital Stock Be In 1 Year?
According to analysts, the consensus estimate is that Advanced Flower Capital share price will rise to $8.76 per share over the next 12 months.
-
What Do Analysts Say About Advanced Flower Capital?
Analysts are divided on their view about Advanced Flower Capital share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Advanced Flower Capital is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Advanced Flower Capital's Price Target?
The price target for Advanced Flower Capital over the next 1-year time period is forecast to be $8.76 according to 6 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is AFCG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Advanced Flower Capital is a Leans Bullish. 3 of 6 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of AFCG?
You can purchase shares of Advanced Flower Capital via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Advanced Flower Capital shares.
-
What Is The Advanced Flower Capital Share Price Today?
Advanced Flower Capital was last trading at $4.53 per share. This represents the most recent stock quote for Advanced Flower Capital. Yesterday, Advanced Flower Capital closed at $4.54 per share.
-
How To Buy Advanced Flower Capital Stock Online?
In order to purchase Advanced Flower Capital stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
